Podcasts about Digital health

“Climate change is the biggest health threat of our century, so we need to train clinicians for a future where it will alter disease patterns, the demand on health systems, and how care is delivered,” says Dr. Sandro Demaio, director of the WHO Asia-Pacific Centre for Environment and Health, underscoring the stakes behind the organization's first regionally-focused climate and health strategy. The five-year plan Dr. Demaio is leading aims to help governments in 38 countries with 2.2 billion people manage rising heat, extreme weather, sea-level change, air pollution and food insecurity by adapting health systems, protecting vulnerable populations, and reducing emissions from the healthcare sector itself. In this timely interview with Raise the Line host Michael Carrese, Dr. Demaio draws on his experiences in emergency medicine, global public health, pandemic response and climate policy to argue for an interconnected approach to strengthening systems and preparing a healthcare workforce to meet the heath impacts of growing environmental challenges. This is a great opportunity to learn how climate change is reshaping medicine, public health and the future of care delivery.  Mentioned in this episode: WHO Asia-Pacific Centre for Environment and Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

As artificial intelligence rapidly enters healthcare, bold claims about replacing doctors dominate headlines. But on the clinical frontline, the reality is far more complex. In this episode of Faces of Digital Health, oncologist Dr. Derrick Khor shares an unfiltered view from inside the NHS, unpacking what AI actually changes — and what it doesn't. Rather than framing AI as a threat, the conversation explores how it already supports clinicians and patients alike: simplifying complex medical information, helping patients understand their diagnoses, and accelerating access to evidence. Yet the biggest constraint isn't technology — it's data. Without reliable access to their own health records, patients and AI tools alike remain limited. The discussion also tackles a growing contradiction in healthcare systems: simultaneous staff shortages and doctor unemployment. Training bottlenecks, hiring freezes, pay erosion, and misaligned workforce planning have created a situation where well-trained clinicians struggle to find roles, even as demand for care continues to rise. Beyond workforce pressures, Dr. Khor explains why most health tech never makes it into daily clinical use. Solutions often fail not because they're unsafe or ineffective, but because they don't fit real workflows. If technology adds friction even a single unnecessary click — clinicians won't adopt it. www.facesofdigitalhealth.com https://fodh.substack.com/

The WHOOP Podcast Longevity Series is back! This week, WHOOP SVP of Research, Algorithms, and Data, Emily Capodilupo sits down with Dr. Ami Bhatt, renowned cardiologist, Chief Innovation Officer at the American College of Cardiology, and the first-ever Chair of Digital Health at the FDA. Dr. Bhatt offers a rare, inside look at how medicine, technology, and policy are coming together to enhance the future of healthcare. From wearables to AI to patient agency and clinician training, this conversation unpacks what it takes to modernize healthcare. Dr. Bhatt shares her personal journey from practicing cardiologist to national innovation leader, highlighting the role of  education, ethics, and human-AI collaboration in creating a better healthcare landscape for patients across the country.(00:53) Intro to Dr. Ami Bhatt, First Chair of Digital Health, FDA(3:20) Seeing AI As A Tool In Healthcare(06:23) Teaching AI: Responsibility & Ethics In Healthcare(09:19) Dr. Bhatt: From Cardiology to Policy(12:21) Role As A Chief Innovation Officer in Healthcare Regulation(16:03) Adjusting Teaching Policies to AI(21:45) Thinking About Wearables: Data Translation & AI(30:38) Technology in Healthcare: Building Algorithms & Navigating FDA ApprovalFollow Dr. Ami BhattLinkedInXSupport the showFollow WHOOP: Sign up for WHOOP Advanced Labs Trial WHOOP for Free www.whoop.com Instagram TikTok YouTube X Facebook LinkedIn Follow Will Ahmed: Instagram X LinkedIn Follow Kristen Holmes: Instagram LinkedIn Follow Emily Capodilupo: LinkedIn

Send us a textAre GLP-1 drugs becoming a long-term foundation of healthcare? In this clip from our episode "What JPM Signals for Healthcare in 2026", CareTalk hosts David Williams and John Driscoll discuss why GLP-1s may be evolving beyond short-term weight loss treatments.Listen to the full episode here

Shannon Burkett has lived about six lives. Broadway actor. SNL alum. Nurse. Filmmaker. Advocate. Cancer survivor. And the kind of person who makes you question what you've done with your day. She wrote and produced My Vagina—the stop-motion musical kind, not the cry-for-help kind—and built a global movement after her son was poisoned by lead dust in their New York apartment. Out of that came LEAD: How This Story Ends Is Up to Us, a documentary born from rage, science, and maternal defiance. We talked about everything from The Goonies to Patrick Stewart to the quiet rage of parenting in a country that treats public health like a hobby. This episode is about art, anger, resilience, and what happens when an unstoppable theater nerd turned science geek Jersey girl collides with an immovable healthcare system.RELATED LINKSShannon Burkett Official SiteLEAD: How This Story Ends Is Up to UsEnd Lead PoisoningLinkedIn: Shannon BurkettBroadwayWorld ProfileFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

FROM SURVIVAL TO QUALITY OF LIFE: WHY OUTCOMES ARE BEING REDEFINED THE FUNDAMENTAL SHIFT IN MEDICINE For decades, medicine measured success through a singular lens: survival. Did the patient live? Did the procedure work? While these metrics remain important, healthcare is undergoing a profound transformation that redefines what "winning" actually means[1]. The new standard is no longer just extending life—it's enabling patients to live purposefully, functionally, and with dignity[2]. This shift reflects a critical insight: surviving is not the same as living well. WHY OUTCOMES ARE BEING REDEFINED Beyond Binary Success Traditional outcome metrics operated in black-and-white terms. A femur repair was "successful" if the fracture healed—regardless of whether the patient could walk without pain, climb stairs, or return to work[3]. Today, healthcare systems recognize this approach as incomplete and outdated. Patient-Reported Outcomes Measures (PROMs) The healthcare industry is now systematically integrating patient voices into outcome measurement. These tools capture what patients actually experience: physical functioning, emotional well-being, social participation, and overall quality of life[4]. The Centers for Medicare & Medicaid Services (CMS) has formally incorporated patient-reported outcome measures into quality reporting frameworks, signaling a structural shift in how healthcare success is defined[5]. The Quintuple Aim Modern healthcare reform is reframing success across five dimensions[6]: ·      Patient Experience: Tailored treatments based on individual data and preferences ·      Population Health: Proactive, preventative care delivery ·      Cost Reduction: Connecting patients to appropriate care and reducing avoidable hospitalizations ·      Provider Well-Being: Extending clinical reach through technology and team-based care ·      Equitable Care: Ensuring access regardless of geography or circumstance WHAT THIS MEANS IN PRACTICE Real-World Impact Advanced remote patient monitoring programs demonstrate the difference this redefinition makes. One program achieved a 230% increase in guideline-directed medical therapy for heart failure patients, adding an average of 5 years to their lives—but the metric that matters most is that patients remained home, maintained independence, and preserved quality of life while achieving better clinical outcomes[7]. Shared Decision-Making Patient preferences now matter. Research shows patients are generally unwilling to accept diminished quality of life simply for extended survival[8]. Healthcare providers increasingly recognize that authentic patient partnership—understanding what matters most to each individual—leads to better adherence, satisfaction, and actual outcomes. THE BOTTOM LINE The redefinition of medical success from "Did you survive?" to "Are you living well?" represents a maturation of healthcare. It acknowledges that modern medicine can often extend life—the question now is how to ensure that extended life is worth living. This shift places patient values, functional abilities, and personal purpose at the center of clinical decision-making. Success in 21st-century medicine means helping patients achieve not just survival, but flourishing. REFERENCES [1] Takeda Oncology. (2025). Living beyond surviving: Patient-centered approach to modern oncology care. Retrieved from https://www.takedaoncology.com/our-stories/living-is-more-than-surviving/ [2] LaBier, D. (2014). Life purpose beyond survival as a metric of quality healthcare. LinkedIn. Retrieved from https://www.linkedin.com/pulse/20140526192226-11896706--life-purpose-beyond-survival-as-a-metric-of-quality-healthcare/ [3] University of South Carolina. (2025). Patient-reported outcome measures essential to clinical decision-making. Retrieved from https://www.sc.edu/uofsc/posts/2025/10/10-patient-centered-quality-measures.php [4] Sermo. (2026). 13 strategies to improve patient care quality in 2026. Retrieved from https://www.sermo.com/resources/13-solutions-for-improving-patient-care-and-outcomes-in-2025/ [5] Medisolv. (2024). Trends in healthcare quality and safety to watch in 2024. Retrieved from https://blog.medisolv.com/articles/healthcare-trends-2024/ [6] Cunningham, E., Chief of Virtual Care and Digital Health, Providence Health. (2024). Cadence outcomes report insights. Cadence Care. Retrieved from https://www.cadence.care/post/cadences-2024-outcomes-report-a-new-era-in-primary-care/ [7] Cadence Care. (2024). Cadence's 2024 outcomes report: A new era in primary care. Retrieved from https://www.cadence.care/post/cadences-2024-outcomes-report-a-new-era-in-primary-care/ [8] PubMed Central. (2008). Patient preferences: Survival vs. quality-of-life considerations. Retrieved from https://pubmed.ncbi.nlm.nih.gov/8410398/

(02:20) Pills that communicate from the stomach could improve medication adherence(07:13) Innovative Solutions for Tracking Medication(10:46) The Technology Behind the Smart Pill(13:42) Conclusion and Future Implications This episode was brought to you by Mouser, our go-to source for electronics parts for any hobby or prototype. Click HERE to learn more about making healthcare smarter with electronics. Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

Cara Munnis was wearing an N95 mask while taking care of her daughter with norovirus all night because she had a critical meeting the next day and "I cannot get this thing." She showed up, ran the meeting, and afterward couldn't tell if anyone noticed she was operating on "one brain cell processing everything." Welcome to being a Chief Product Officer and a mom. Here's what most people don't know about the CPO role: it has the shortest tenure of any C-suite position—less than half that of other executives. You're supposed to be "Switzerland," the neutral party among competing stakeholders. But you're constantly telling your C-suite peers—very kindly—why their ideas are going to sink or swim. The real transformation wasn't navigating those politics. It was what happened when Cara's daughter was born seven years ago. "For someone who's led massive technology transformations multiple times, it's very ironic how hard this transition was for me." The evening checkboxes—that sacred 5-8pm window where she prepared for the next day—vanished instantly. It took five years to build a new operating system where she hired without compromise and delegated with her eyes closed. In this conversation, Cara explains why she's "obsessed" with finding the economic denominator, why Conway's Law means your product will mirror your org structure, and why staying close to technology was the best career advice she ever got. After describing her relentless discipline and surgical precision, she deadpans: "I haven't been fired yet, so I dunno, I guess it's okay." This is a masterclass in product leadership that scales, parenting that doesn't apologize, and ruthless prioritization when you're scraping for minutes in your day. Key Takeaways: How to choose the right ladder to climb—make career decisions based on intentionality, not just opportunity or speed How to turn constraints into leadership advantages—use the pressure of working parenthood to force yourself to hire without compromise and delegate with confidence How to stay close to technology in any role—even as a non-technical leader, understanding architecture helps you defend budgets, win deals, and articulate competitive advantages How to shift your communication style as you move into executive roles—listen more, ask questions even when you know the answer, and bring others along instead of leading with your opinion How to design org structures that create better products—use Conway's Law (products mirror internal communication structures) to intentionally build teams that will produce the outcomes you want About the Guest: Cara Munnis is Chief Product Officer at Care Lumen and Operating Partner at Newfire Global Partners, bringing over 15 years of healthcare technology product leadership to organizations navigating the intersection of clinical outcomes and business results. She spent six years at Amwell advancing from Senior Director to VP of Product Management, previously served as Head of Product for Digital Health at Blue Shield of California, and held leadership roles at Iora Health and Best Doctors. With a pre-med degree from College of the Holy Cross and an MBA from Bentley University, Cara is Pragmatic Marketing Certified – Level III and known for her ability to balance strategic product vision with rigorous execution while fostering collaborative team environments. Chapters [Placeholder for Chapters] Guest & Host Links Connect with Laurie McGraw on LinkedIn Connect with Cara Munnis on LinkedIn Connect with Inspiring Women Browse Episodes | LinkedIn | Instagram | Apple | Spotify

CES '26 Digital Health Tour New wearables and connected personal health devices dominated the digital health hall at CES '26. Jared gives you a tour of what caught his eye, including news from Bhuvan Srinivasan, Chief Business Officer at Ultrahuman, Bruno Carriel, Head of Product Development at Withings, and Jonathon Baggia, Global Marketing Manager for Renpho.  All that, plus our Shout Out to listeners in the GLP-1 space.  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

It has been said that we don't have “big data” in healthcare, but instead a large amount of “small data.”In this episode, Halle speaks with Kyle Armbrester, CEO of Datavant and former CEO of Signify Health (acquired for $8B), about why healthcare data still moves the way it did decades ago and what it will take to modernize it at scale. Kyle reflects on building and leading large health tech companies and explains how fixing data flow could reduce administrative waste, improve security, and make care easier for patients and providers alike.We cover:Why healthcare billing still happens after the fact and how that fuels administrative wasteHow missing data standards led to fax-based workflows and brittle systemsWhy healthcare data is such an attractive target for cyberattacksHow clinical data can be shared digitally without being owned or resoldLeadership lessons from scaling companies through IPOs and acquisitions—About our guest: Kyle Armbrester is Chief Executive Officer of Datavant, a healthcare data platform company with a mission to make the world's health data secure, accessible, and actionable. Datavant operates the largest and most diverse health data exchange in the U.S., connecting more than 70 percent of the 100 largest health systems, all U.S. payers, and 300 plus real world data partners.Previously, Kyle served as CEO of Signify Health, where he led more than 200 percent revenue growth, took the company public in 2021, and guided its acquisition by CVS Health in 2023 for approximately $8 billion. He later served on the CVS Health executive management team, overseeing healthcare delivery strategy and interoperability.Earlier in his career, Kyle was Chief Product Officer and Head of Corporate Development at athenahealth, where he helped scale revenue from $320 million to $1.2 billion and launched the company's partnership marketplace. Kyle has served on multiple healthcare boards and holds an MBA and AB from Harvard University.—Chapters:00:01:20 Introduction to Kyle Armbrester and his journey in healthcare00:03:58 The impact of Athena Health on healthcare innovation00:06:20 Datavant: Revolutionizing health data interoperability00:08:15 The role of Datavant in reducing administrative burden00:12:20 Understanding Datavant's value proposition across stakeholders00:14:00 Consumer products and data accessibility at Datavant00:18:25 The scale and impact of Datavant in healthcare00:19:35 Cybersecurity challenges in healthcare data management00:23:57 Bridging the gap in healthcare regulations00:26:13 Unlocking the value of untapped healthcare data00:29:25 Challenges of value-based care models00:33:23 The reality of being a CEO in healthcare00:37:00 Navigating IPOs vs. Acquisitions00:39:44 Innovating healthcare incentives for better outcomes—Pre-order Halle's new book, Massively Better Healthcare.—

Family physician Tod Stillson discusses his article "Why AI in medicine elevates humanity instead of replacing it." Tod explains how his career evolution revealed that artificial intelligence is not a threat to the medical profession but a necessary tool for reshaping care delivery. He argues that physicians must actively lead the integration of AI to ensure that clinical judgment is amplified rather than overridden by automation. The conversation covers the necessity of digital fluency, the shift toward structured asynchronous data collection, and how these technologies can actually restore the human connection by relieving administrative burdens. Listen to discover why the next generation of doctors must master both stethoscopes and software to meet evolving patient expectations. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Send us a textAI, GLP-1s, federal policy, and China. Those themes dominated last week's JP Morgan Health Care Conference in San Francisco. But what, if anything are the implications for the broader healthcare world in 2026?Hosts David Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health discuss what stood out most at JPM, including why the GLP-1 wave may be entering a new phase, how Big Tech and AI are reshaping the healthcare landscape, and why China's growing presence in biotech is becoming harder to ignore.

We have a special episode of Raise the Line on tap today featuring the debut of host Dr. Parsa Mohri, who will now be leading our NextGen Journeys series that highlights the fresh perspectives of learners and early career healthcare professionals around the world on education, medicine, and the future of care. Parsa was himself a NextGen guest in 2024 as a medical student at Acibadem University in Turkey. He's now a general physician working in the Adult Palliative Care Department at Şişli Etfal Research and Training Hospital in Istanbul.  Luckily for us, he's also continuing in his role as a Regional Lead for the Osmosis Health Leadership Initiative (OHLI). For his first guest, Parsa reached out to a former colleague in the Osmosis family, Negeen Farsio, who worked with him as a member of OHLI's predecessor organization, the Osmosis Medical Education Fellowship. Negeen is now a graduate student in medical anthropology at Brunel University of London, a degree which she hopes will inform her future work as a clinician. “Medical anthropology is a field that looks at healthcare systems and how human culture shapes the way we view different illnesses, diseases, and treatments and helps you to see the full picture of each patient.” You are sure to enjoy this heartfelt conversation on how Negeen's lived experience as a patient and caregiver have shaped her commitment to mental health and patient advocacy, and how she hopes to marry humanity with medicine in a world that yearns to heal. If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Ambient documentation is becoming normal in clinics. But the most interesting “voice” capability may not be transcription at all.In the latest episode of Faces of Digital Health, Henry O'Connell (Canary Speech) explains why voice biomarkers stalled for decades: the field analyzed words, not the neurological signal behind speech production.Canary's approach focuses on the “primary data layer”—how the central nervous system drives respiration, vocal cord vibration, and articulation in real conversational speech. A few details that stood out: ⏱️ ~45 seconds of conversation can be enough for assessment

When to Trust the Machine: AI Decision-Making in Healthcare with Professor Vasant Dhar Host Megan Antonelli Guest: Vasant Dhar, Author, Thinking With Machines: The Brave New World of AI Join host Megan Antonelli and her guest Professor Vasant Dhar, Author, Thinking With Machines: The Brave New World of AI for part one of a two-part interview. As AI systems increasingly influence clinical decisions, healthcare leaders face a critical question: When can we safely rely on AI, and when must human judgment remain in the loop? Professor Dhar delivers a practical framework for evaluating AI reliability, recognizing model blind spots, and designing guardrails that actually work, offering rare clarity on the tension between rapidly advancing AI capabilities and our ability to evaluate their trustworthiness. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Michael Kramer was 19 when cancer ambushed his life. He went from surfing Florida beaches to chemo, radiation, and a bone marrow transplant that left him alive but carrying a chronic disease. He had necrosis in his knees and elbows, lost his ability to surf for years, and found himself stuck in hospitals instead of the ocean. Yet he adapted. Michael picked up a guitar, built Lego sets, led support groups, and started sharing his story on Instagram and TikTok.We talk about masculinity, identity, and what happens when the thing that defines you gets stripped away. He opens up about dating in Miami, freezing sperm at a children's hospital, awkward Uber-for-sperm moments with his brother, and how meditation became survival. Michael lost his father to cancer when he was a teen, and that grief shaped how he lives and advocates today. He is funny, grounded, and honest about the realities of survivorship in your twenties. This episode shows what resilience looks like when you refuse to walk it off and choose to speak it out loud instead.RELATED LINKSMichael Kramer on InstagramMichael Kramer on TikTokMichael and Mom Inspire on YouTubeAshlee Cramer's BookUniversity of Miami Sylvester Comprehensive Cancer CenterStupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Our analysts (or “bakers”) compete in a Great British Bake Off–style episode, discussing why Dr. Google will give way to Dr. ChatGPT in 2026 and how Americans will increasingly use AI for mental health therapy and support this year. Join Senior Director of Podcasts and host Marcus Johnson, along with Senior Analysts Rajiv Leventhal and Beth Snyder Bulik. Listen everywhere, and watch on YouTube and Spotify.   Report mentioned: https://content-na1.emarketer.com/health-trends-watch-2026   Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-great-btn-bake-take-off-digital-health-trends-2026-dr-chatgpt-ai-therapy-behind-numbers © 2026 EMARKETER

Digital health is moving at AI speed, but evidence generation is still stuck in the past. In this episode, StartUp Health co-founder Unity Stoakes sits down with StartUp Health community member Robin Roberts, CEO & Founder of datosX Digital Health Labs, to explore how validation can become a catalyst for real-world adoption rather than a bottleneck. Drawing on his experience building the Novartis Biome and spinning datosX out of it, Robin explains why traditional CRO models no longer meet the needs of modern digital health and AI-powered solutions. Together, they discuss how datosX is helping innovators generate regulatory-grade, buyer-credible evidence while unlocking pilots and commercial traction with leading health systems. In this conversation, you will learn: Why digital health companies cannot afford to wait 18 months for validation How datosX pairs innovators with tier-1 health systems to run validation studies that double as pilots What makes the datosX model 30–60% faster and up to 8–10× more cost-effective than legacy CROs How real-world data and retrospective studies accelerate proof and decision-making Why evidence, adoption, and trust must be built together How the upcoming EVIDIA platform is turning global digital health trial knowledge into AI-powered intelligence This episode is a must-listen for founders, health system leaders, investors, and partners working to bring validated, trustworthy health innovation to market faster. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

This week, Steve sits down with Ankit Jain, co-founder and CEO of Infinitus Systems, to talk about why voice-based AI has become one of the most rapidly adopted tools in healthcare operations, what's actually working in the field, and where the hype still outpaces reality. Ankit shares six years of lessons from building AI agents that handle 35-minute medical calls end to end, plus his predictions on what 2026 and 2027 will really look like as enterprises attempt to build their own agents.We cover:Why so much of healthcare still runs on phones, faxes, and portalsHow AI agents are handling long, high-stakes medical calls without going off trackWhat large enterprises now expect around security, governance, and zero-hallucination requirementsWhy providers, payers, and pharma are adopting AI for different operational workflowsWhy 2026 may be the year many health systems try to build their own agents, and why most will return to vendors by 2027—About our guest: Ankit Jain is the co-founder and CEO of Infinitus Systems, the agentic healthcare communications platform that automates high-stakes clinical and administrative conversations at scale. Under his leadership, Infinitus supports 44% of the Fortune 50, and many of the largest healthcare organizations in the US. A serial entrepreneur, advisor, and investor, Ankit has built companies and guided innovation at the intersection of technology and AI. He founded Quettra (acquired by Similarweb), helped launch Google Play and the search engine Cuil, and went on to co-found and manage Gradient Ventures, Google's AI-focused venture fund. His background in building distributed systems and safety-constrained AI, combined with hands-on experience scaling products in regulated environments, gives him a pragmatic perspective on how to design trustworthy AI that earns adoption in healthcare. Ankit frequently works with industry leaders on governance, education, and integration strategies that make automation safe, approachable, and scalable.—Chapters:00:01:38 Introduction to Ankit Jain and Infinitus Systems00:02:54 The journey into healthcare entrepreneurship00:03:55 Inspiration behind Infinitus and its mission00:04:55 Evolution of AI in healthcare communications00:08:12 Navigating competition in the AI healthcare space00:10:30 Defensibility and product development insights00:14:00 AI's role in enhancing healthcare accessibility00:15:20 Go-to-Market strategies and lessons learned00:17:52 Deepening engagement in healthcare workflows00:19:33 Competitive dynamics in healthcare AI00:20:42 Addressing industry concerns and challenges00:22:14 The need for industry self-regulation00:23:40 Navigating consumer privacy and AI interactions00:25:27 The future of jobs in healthcare AI00:28:30 The evolution of healthcare AI00:29:37 Lessons for entrepreneurs in healthcare—Pre-order Halle's new book, Massively Better Healthcare.—

CES 2026 Just Showed Us the Future. It's More Practical Than You Think.CES has always been part crystal ball, part carnival. But something shifted this year.I caught up with Brian Comiskey—Senior Director of Innovation and Trends at CTA and a futurist by trade—days after 148,000 people walked the Las Vegas floor. What he described wasn't the usual parade of flashy prototypes destined for tech graveyards. This was different. This was technology getting serious about actually being useful.Three mega trends defined the show: intelligent transformation, longevity, and engineering tomorrow. Fancy terms, but they translate to something concrete: AI that works, health tech that extends lives, and innovations that move us, power us, and feed us. Not technology for its own sake. Technology with a job to do.The AI conversation has matured. A year ago, generative AI was the headline—impressive demos, uncertain applications. Now the use cases are landing. Industrial AI is optimizing factory operations through digital twins. Agentic AI is handling enterprise workflows autonomously. And physical AI—robotics—is getting genuinely capable. Brian pointed to robotic vacuums that now have arms, wash floors, and mop. Not revolutionary in isolation, but symbolic of something larger: AI escaping the screen and entering the physical world.Humanoid robots took a visible leap. Companies like Sharpa and Real Hand showcased machines folding laundry, picking up papers, playing ping pong. The movement is becoming fluid, dexterous, human-like. LG even introduced a consumer-facing humanoid. We're past the novelty phase. The question now is integration—how these machines will collaborate, cowork, and coexist with humans.Then there's energy—the quiet enabler hiding behind the AI headlines.Korea Hydro Nuclear Power demonstrated small modular reactors. Next-generation nuclear that could cleanly power cities with minimal waste. A company called Flint Paper Battery showcased recyclable batteries using zinc instead of lithium and cobalt. These aren't sexy announcements. They're foundational.Brian framed it well: AI demands energy. Quantum computing demands energy. The future demands energy. Without solving that equation, everything else stalls. The good news? AI itself is being deployed for grid modernization, load balancing, and optimizing renewable cycles. The technologies aren't competing—they're converging.Quantum made the leap from theory to presence. CES launched a new area called Foundry this year, featuring innovations from D-Wave and Quantum Computing Inc. Brian still sees quantum as a 2030s defining technology, but we're in the back half of the 2020s now. The runway is shorter than we thought.His predictions for 2026: quantum goes more mainstream, humanoid robotics moves beyond enterprise into consumer markets, and space technologies start playing a bigger role in connectivity and research. The threads are weaving together.Technology conversations often drift toward dystopia—job displacement, surveillance, environmental cost. Brian sees it differently. The convergence of AI, quantum, and clean energy could push things toward something better. The pieces exist. The question is whether we assemble them wisely.CES is a snapshot. One moment in the relentless march. But this year's snapshot suggests technology is entering a phase where substance wins over spectacle.That's a future worth watching.This episode is part of the Redefining Society and Technology podcast's CES 2026 coverage. Subscribe to stay informed as technology and humanity continue to intersect.Subscribe to the Redefining Society and Technology podcast. Stay curious. Stay human.> https://www.linkedin.com/newsletters/7079849705156870144/Marco Ciappelli: https://www.marcociappelli.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Part Two: When to Trust the Machine: AI Decision-Making in Healthcare with Professor Vasant Dhar Join us for part two of a two-part interview with Professor Vasant Dhar, NYU Stern professor, veteran AI researcher, and author of Thinking With Machines: The Brave New World of AI. As AI systems increasingly influence clinical decisions, healthcare leaders face a critical question: When can we safely rely on AI, and when must human judgment remain in the loop? Professor Dhar delivers a practical framework for evaluating AI reliability, recognizing model blind spots, and designing guardrails that actually work, offering rare clarity on the tension between rapidly advancing AI capabilities and our ability to evaluate their trustworthiness. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us a textUnsurprisingly, AI dominated the headlines at this year's JPMorgan Healthcare Conference, but there were some other exciting developments that shouldn't be overlooked.CareTalk hosts, David Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, share their on-the-ground insights from JPM, including where AI is delivering substance over hype, why government partnership will play a larger role in health sector reform, and what's driving a renewed sense of optimism across healthcare.

New research is transforming the outlook for cervical and uterine cancers -- two of the most serious gynecologic malignancies worldwide – and we'll be hearing from one of the people shaping that progress, Dr. Mary McCormack, on this episode of Raise the Line. From her perch as the senior clinical oncologist for gynecological cancer at University College London Hospitals, Dr. McCormack has been a driving force in clinical research in the field, most notably as leader of the influential INTERLACE study, which changed global practice in the treatment of locally advanced cervical cancer, a key reason she was named to Time Magazine's 2025 list of the 100 most influential people in health. “In general, the protocol has been well received and it was adopted into the National Comprehensive Cancer Network guidelines which is a really big deal because lots of centers, particularly in South and Central America and Southeast Asia, follow the NCCN's lead.”In this conversation with host Michael Carrese, you'll learn about how Dr. McCormack overcame recruitment and funding challenges, the need for greater access to and affordability of treatments, and what lies ahead for women's cancer treatment worldwide. Mentioned in this episode:INTERLACE Cervical Cancer Trial If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this episode of WCG Talks Trials, host Gabriella Tost sits down with Latin America regional experts Mercedes Lopez, Camila Santos, and Sebastian Florez to explore how artificial intelligence, telemedicine, and wearable technologies are reshaping clinical research across Latin America. From expanding access through virtual care to empowering patients with biosensors, the conversation highlights how digital tools are breaking longstanding barriers to participation — especially for rural and underserved communities. The group dives into the growing role of AI in participant identification, site selection, and overcoming fragmented health records — challenges historically unique to the region. They also discuss rapid regulatory modernization in countries like Brazil, Mexico, and Ecuador, which is accelerating approvals, enabling decentralized trials, and fostering a fertile environment for global investment. Looking ahead, the experts paint an exciting picture of what research will look like by 2026: connected data ecosystems, hybrid study models, stronger community engagement, and more inclusive recruitment than ever before. Whether you're a sponsor, site, or technology innovator, this episode offers clear insights into why Latin America is becoming a global leader in digital-forward, participant-centered clinical trials. For more into these insights, read their article, “AI and the Digital Future of Health in Latin America: A Sponsor's Opportunity,” in the 2026 Trends & Insights Report.  

Most of us can remember those pit-in-the-stomach times we experienced as teenagers when we realized we had been left out. I remember a summer day in the neighborhood when I couldn't find any of my friends at home. I couldn't figure out why they were all gone until somebody spilled the beans later, telling me that they had all been invited to go to a home in another neighborhood to swim in the families' pool. Truth be told, I felt like a loser. The journal Frontiers in Digital Health reports that for kids living in today's social media world, the feelings I felt on that one summer day occur far more frequently, as our kids see visual and story content recounting activities and gatherings of friends from which they've been excluded. This ramps up feelings of exclusion, jealousy, and rejection. Researchers say this is feeding emotional stress and creating interpersonal conflict. Let's use these moments to teach our kids to handle disappointment and conflict with the kindness and grace of Jesus Christ. 

Daniel Garza had momentum. Acting roles, directing gigs, national tours lined up. Then anal cancer stopped everything. Radiation wrecked his body, stripped him of control, and left him in diapers, staring down despair. His partner, Christian Ramirez, carried him through the darkest nights, changed his wounds, fought hospitals, and paid the price with his own health. Christian still lives with permanent damage from caregiving, but he stayed anyway.Together they talk with me about masculinity, sex, shame, friendship, and survival. They describe the friendships that vanished, the laughter that kept them alive, and the brutal reality of caregiving no one prepares you for. We get into survivor guilt, PTSD, and why even rocks need rocks. Daniel is now an actor, director, and comedian living with HIV. Christian continues to tell the unfiltered truth about what it takes to be a caregiver and stay whole. This episode gives voice to both sides of the cancer experience, the survivor and the one who stands guard. RELATED LINKSDaniel Garza IMDbDaniel Garza on InstagramDaniel Garza on FacebookChristian Ramirez on LinkedInLilmesican Productions Inc (Daniel & Christian)Stupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jan 12, 2026 – Imagine transforming your home into a state-of-the-art wellness center—that's the future showcased at this year's Consumer Electronics Show. From AI-powered health devices and non-invasive wearables to personalized...

Is 2026 the year that changes everything in healthcare?Steve and Halle sit down with legendary healthcare VC Annie Lamont for their annual predictions episode to dive into 2026 predictions and trends that founders and operators should pay attention to. We cover:

Send us a textReferrals are meant to connect patients to the care they need, but in reality, they often become a source of delays, dropped handoffs, and administrative chaos. Between intake complexity, missing information, and outdated processes, too many patients get stuck between diagnosis and treatment. Trey Holterman, Co-Founder and CEO of Tennr joins CareTalk host John Driscoll to discuss why referrals break down so often, what makes intake workflows so hard to fix, and how health systems can improve throughput and access without ripping out the systems they already rely on. 

#TheShot of #DigitalHealth 2026 episode almost didn't happen - Jim Joyce was in the air, I was back in cold New Jersey, and Max was somewhere warm and productive (naturally). But missing it would've been a mistake. Max Marchione, founder of Superpower, joined me for a wide-ranging conversation on why modern healthcare is fundamentally broken - and why diagnostics, AI, data, and first-principles thinking might finally fix it. We talked about: - Growing up with chronic health issues no doctor could explain - Why “10x doctors” exist - and why most medicine can't scale them - How AI will soon outperform humans at clinical reasoning - And what it actually takes to scale a healthcare startup without losing your soul This wasn't a polished healthcare panel. It was a real conversation about truth, tradeoffs, and taking massive action - even when you know you'll mess some of it up. If you're building in health, longevity, AI, or just trying to feel better in your own body… this one's worth your time.

“The world is a very volatile place, with currently 110 conflicts globally, and yet healthcare staff in the hospitals, even here in London, are not prepared to be the only clinician who can help in a crisis or hostile setting,” says Dr. David Gough, CEO of the David Nott Foundation, which equips providers with the skills and confidence needed to function in war and other extraordinary situations. A former British Army doctor injured in Afghanistan, Gough brings lived experience as well as a background in tech to his current role at the Foundation, which itself is anchored in decades of field work amassed by its namesake, a renowned war surgeon. As Dr. Gough points out to host Lindsey Smith, the cause could be helped by augmenting medical school curricula, but in the meantime, the Foundation is filling the knowledge gap by using prosthetics, virtual reality simulations and cadavers to train a broad swath of health workers including surgeons, anesthetists, and obstetricians. Tune in to this important Raise the Line conversation as Dr. Gough reflects on the strengths and weaknesses of NGOs in doing this work, his plans to expand the Foundation's footprint in the US, and the gratifying feedback he's received from trainees now operating on the frontlines in Ukraine and elsewhere. Mentioned in this episode:David Nott Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Host: Megan Antonelli Guest: Monica Cepak, CEO, Wisp Join Megan Antonelli and her guest, Monica Cepak, CEO of Wisp for insights on an exclusive evening of networking and insights at the HLTH 2025 Provider Think Tank, hosted by HFMA SoCal on October 6th in Las Vegas. This intimate gathering brought together healthcare executives and industry leaders to explore the latest innovations in revenue cycle management, digital health transformation, and clinical operations. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Join us on the latest episode, hosted by Jared S. Taylor!Our Guests: Dan D'Orazio, CEO, Sage Growth Partners, and Christina Speck, Chief Solutions & AI Officer, Sage Growth Partners.What you'll get out of this episode:Strategic AI Adoption: Leaders must align AI tools with real business problems, not just adopt technology for its own sake.Enterprise Change Management: Success hinges more on people and process readiness than on the AI technology itself.Human + AI Synergy: The rise of “HI + AI” and “HSI” (Humanist Super Intelligence) models puts empathy at the center of AI innovation.Clinical & Administrative Focus: Real AI excitement lies in automating repetitive administrative tasks, with clinical applications gaining cautious momentum.Sage's Growth-Centric AI Model: From readiness to impact, Sage Growth Partners tailors AI strategies to support each client's growth journey.To learn more about:Website http://www.sage-growth.comLinkedin https://www.linkedin.com/company/sage-growth-partners/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Pete Shalek, founder of Valerie Health, is a multi-time healthcare entrepreneur who previously founded Joyable in 2013 (one of the earliest digital mental health platforms) and served as Chief Product Officer at AbleTo and Stellar Health. Pete discusses why AI in healthcare needs to move beyond selling software tools to actually doing the work for providers. He shares hard-won lessons from a decade in digital health, including why the shift to quality-based care in behavioral health has been surprisingly slow and why Joyable's therapist-free model was ahead of its time relative to payment models. The conversation covers Valerie's approach of building an AI front office that handles referrals, scheduling, and intake for independent medical practices without requiring them to learn new software, achieving 3-4 week implementations and 5-7% conversion lifts. Pete explains the technical challenges of structuring unstructured healthcare data with 100% accuracy, the strategic choice to own operations end-to-end rather than just provide tools, why referrals are the perfect wedge product as the most upstream data point, and his evolving views on how quickly AI will impact the gray area between administrative and clinical work. Throughout, he emphasizes the importance of meeting healthcare where it is (turning faxes into structured data rather than trying to force system-wide transformation) and building for today's payment models while working toward a bigger vision. (0:00) Intro(0:52) Pete's Journey in Digital Health(1:45) Challenges in Behavioral Health(3:38) Valerie Health: An AI Front Office(4:47) Valerie's Unique Approach to Software(6:16) Customer-Centric Solutions(8:38) Data and AI in Healthcare(10:19) Building a Successful Health Tech Company(13:19) Future of AI in Healthcare(16:16) Operational Challenges and Solutions(28:57) Pricing and Value Delivery(30:12) Quickfire Out-Of-Pocket: https://www.outofpocket.health/

Today we will focus our discussion on AI and Digital Health and FDA's Evolving Oversight. The FDA has been actively shaping its regulatory framework for AI and machine learning in medical devices, recognizing that traditional device regulations were designed for static products not adaptive algorithms that learn over time.Questions and Comments: wkirton@bakerlaw.com, jsherer@bakerlaw.com, avold@bakerlaw.com

Trevor Maxwell lived the archetype of masculinity in rural Maine. Big, strong, splitting wood, raising kids, and carrying the load. Then cancer ripped that script apart. In 2018 he was bedridden, emasculated, ashamed, and convinced his family would be better off without him. His wife refused to let him disappear. That moment forced Trevor to face his depression, get help, and rebuild himself. Out of that came Man Up To Cancer, now the largest community for men with cancer, a place where men stop pretending they are bulletproof and start being honest with each other.Eric Charsky joins the conversation. A veteran with five cancers, forty-nine surgeries, and the scars to prove it, Eric lays out what happens when the military's invincible mindset collides with mortality. Together, we talk masculinity, vulnerability, sex, shame, and survival. This episode is blunt, raw, and overdue.RELATED LINKSMan Up To CancerTrevor Maxwell on LinkedInDempsey CenterEric Charsky on LinkedInStupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

From Food Allergy Parent to Published Author and CEO: Meenal Lele on Building an Evidence-Based Prevention Company as Delaware Mandates Insurance Coverage As Delaware implements the nation's first insurance mandate for early allergen introduction on January 1st, 2026, Meenal Lele, Founder & CEO of Lil Mixins and author of The Baby and the Biome, shares her journey from food allergy parent to medical entrepreneur. With multiple patents, published clinical studies, and an engineering background, Meenal built Hanimune Therapeutics to address a crisis affecting 33 million Americans. She discusses the clinical evidence behind early allergen introduction, navigating insurance coverage, and why state-level policy changes matter for reducing childhood allergies while saving healthcare systems millions. Discover how maternal insight combined with scientific rigor is transforming prevention. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

The most anticipated annual tradition on Out of Patients returns with the 2025 Holiday Podcast Spectacular starring Matthew's twins Koby and Hannah. Now 15 and a half and deep into sophomore year, the twins deliver another unfiltered year end recap that longtime listeners wait for every December. What began as a novelty in 2018 has become a time capsule of adolescence, parenting, and how fast childhood burns off.This year's recap covers real moments from 2025 A subway ride home with a bloodied face after running full speed into that tree that grows in Brooklyn. Broadway obsessions fueled by James Madison High School's Roundabout Youth Ensemble access, including Chess, & Juliet, Good Night and Good Luck, and Pirates of Penzance holding court on Broadway. A Disneylanmd trip where the Millennium Falcon triggered a full system reboot. A New York Auto Show pilgrimage capped by a Bugatti sighting. All the things.The twins talk school pressure, AP classes, learner permit anxiety, pop culture fixation, musical theater devotion, and the strange clarity that comes with turning 15. The humor stays sharp, the details stay specific, and the passage of time stays undefeated. This episode lands where the show works best: family, honesty, and letting young people speak for themselves.FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What's new at CES 2026? From the debut of CES Foundry for AI and quantum to show‑wide robotics, digital health and an expanded Creator Space, CTA's leaders — Gary Shapiro, Kinsey Fabrizio and John T. Kelley — come together for an insider look at what's ahead in Las Vegas. They explore how these trends will show up across the newly renovated LVCC, Eureka Park, stages and beyond. If you're gearing up for CES, listen in for the scoop on keynotes, the show floor, and what this trio can't wait to see.

Vitamin C, vitamin D, collagen, creatine, magnesium. All of them can be found in supermarkets, wellness shops and of course, online. These products, also known as supplements, have gained so much popularity that the global market has an estimated value of over $150 billion. But do they actually work and what's the science behind them? The BBC's Digital Health editor Michelle Roberts unpacks some of the most popular supplements for us. Plus we hear from people around the world about why they've decided to include them in their diet. Instagram: @bbcwhatintheworld Email: whatintheworld@bbc.co.uk WhatsApp: +44 330 12 33 22 6 Presenter: William Lee Adams Producers: Chelsea Coates, Rio Rennalls and Maria Clara Montoya Editor: Emily Horler

Blood Pressure Control Crisis in Primary Care: New AI Study Reveals What's Going Wrong Join us as Dr. Andrew M. Davis and Amy Wainwright from University of Chicago Medicine reveals how AI-powered analysis of 37,000+ patients exposed a crisis hiding in plain sight: nearly 30% of hypertensive patients have dangerously uncontrolled blood pressure despite regular primary care visits. Using cloud-based machine learning across 112 providers, Dr. Davis's team identified critical gaps traditional metrics miss—underutilized medications, missed referrals, and troubling disparities in care. More importantly, they developed interventions that work. Discover how to leverage advanced analytics for measurable ROI, implement real-time clinical intelligence at scale, and empower providers with data-driven feedback that reduces cardiovascular risk at the point of care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Jason Gilley walked into adulthood with a fastball, a college roster spot, and a head of curls that deserved its own agent. Cancer crashed that party and took him on a tour of chemo chairs, pediatric wards, metal taste, numb legs, PTSD, and the kind of late night panic that rewires a kid before he even knows who he is.I sat with him in the studio and heard a story I know in my bones. He grew up fast. He learned how to stare down mortality at nineteen. He found anchors in baseball, therapy, and the strange friendships cancer hands you when it tears your plans apart. He owns the fear and the humor without slogans or shortcuts. Listeners will meet a young man who refuses to let cancer shrink his world. He fights for the life he wants. He names the truth without apology. He reminds us that survivorship stays messy and sacred at the same time. This conversation will stay with you.RELATED LINKS• Jason Gilley on IG• Athletek Baseball Podcast• EMDR information• Children's Healthcare of AtlantaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 79 It's Not Capability, It's Design: Digital Health Equity (HLTH) On this episode host Raj Sundar dives into the inspiring stories of Dr. Fernandez and Dr. Gigi Magan family medicine physicians and co-founders of Alma First. They explore the challenges they observed during the pandemic with digital health disparities in underserved communities and how those moments sparked their mission to promote digital health equity. Together, they discuss the importance of digital health navigators, training pre-health students through equity-centered curricula, and practical ways they introduce technology—like continuous glucose monitors and patient portals—to communities often overlooked by innovation. They also reflect on the need for culturally sensitive, accessible healthcare tech, the impact of provider engagement, and how we can keep evolving our patient education to truly meet people where they are. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode, Dipak Kalra, President of the European Institute for Innovation through Health Data, joins Faces of Digital Health to break down the real progress (and real gaps) in European health data, from legacy “hybrid” paper/digital workflows to the underused potential of clinical decision support that depends on structured data. We explore what EHDS changes—especially the promise of a standardized, downloadable patient dataset—and what it could unlock for patient-facing apps, analytics, and more active self-management. We also tackle the hard questions: how to protect citizens from misuse and scams, how opt-out choices might create bias in research and AI, why “beating clinicians with a stick” won't fix data quality, and why delays aren't just bureaucratic—they can translate into avoidable harm. 02:00 The State of Healthcare Data in Europe 07:59 Challenges in Data Interoperability 12:31 The Role of Patients in Data Management 16:37 AI and Data Privacy Concerns 22:01 Patient Consent and Data Usage 28:00 Optimism for the Future of Health Data 31:03 Optimistic Futures for EAGDS 33:02 Preparing for EHDs: Readiness and Challenges 35:48 Data Quality and Workforce Challenges 37:58 Delays and Future Discussions on EHDs 39:53 The Urgency of Health Data Readiness 42:38 The Evolving Role of Patients in Healthcare 50:19 Building Trust Among Healthcare Stakeholders 57:58 The Future of Healthcare Data Discussions

What if our smartest health tools still miss the people who need them most? We sit down with AI and digital health scientist Mireille Gomes to examine how innovation can serve dignity, not just efficiency—and what it takes to build technology that works from Geneva to rural clinics without electricity.The journey of Mireille Gomes spans continents and roles, from vaccine strategy at Gavi to AI diagnostics at Merck. Together, we unpack the real barriers to deployment—uneven infrastructure, overworked staff, and data voids that erase entire communities from the record. We look at consent‑first design, why open data must be truly anonymous, and how representation in civil registration and vital statistics underpins every “fair” algorithm. You'll hear pragmatic ideas for triage tools that flag urgency in seconds, health education in local languages, and micro‑local models that adapt to context while sharing standards globally.We also push on the hard questions: Who decides which data matters? Can algorithms be biased toward justice if the world is not? Where is the line between breakthrough and overreach when crises demand speed? Mirielle argues for building abuse cases into development, testing for misuse before launch, and preserving community storytelling—especially Indigenous knowledge—alongside dashboards. The goal is health equity by design, so no one's care depends on their birthplace or bandwidth.If you care about AI in healthcare, data justice, and solutions that actually work on the ground, this conversation offers a clear roadmap and candid guardrails. If it resonates, subscribe, leave a review, and share it with someone shaping the future of digital health.Send us a textCheck out "Protection for the Inventive Mind" – available now on Amazon in print and Kindle formats. The views and opinions expressed (by the host and guest(s)) in this podcast are strictly their own and do not necessarily reflect the official policy or position of the entities with which they may be affiliated. This podcast should in no way be construed as promoting or criticizing any particular government policy, institutional position, private interest or commercial entity. Any content provided is for informational and educational purposes only.

Nothing was said.Marcus Perez, CEO of Altera Digital Health, described a moment that began as a mistake and still shapes how he leads thousands today.No meeting followed.No email.No correction in the usual sense.Instead, the situation escalated.The next day, someone more senior took control — not to punish, not to explain — but to recreate the risk.Closer.Lower.Long enough to make the point unavoidable.What stayed with me wasn't the danger...It was the restraint.The decision to teach without reacting.To let accountability come after understanding.And to trust that the moment itself would do the work.As our conversation unfolded, beyond that incident — into pressure, truth, and why leaders often default to intensity when something else is required.It's the kind of leadership moment that doesn't feel dramatic at first…but quietly rewires how you show up years later.Ever taught or learned a lesson where nothing needed to be said?-----Connect with the Host, #1 bestselling author Ben FanningSpeaking and Training inquiresSubscribe to my Youtube channelLinkedInInstagramTwitter

Food as Medicine: Dr. Elizabeth Klodas – Disrupting Cardiology with Clinical Nutrition Join us as we explore a critical question: What if the solution to America's number one killer isn't in the pharmacy, but in the kitchen? Today's guest is Dr. Elizabeth Klodas, a Mayo Clinic and Johns Hopkins-trained cardiologist who founded Step One Foods after realizing that doctors, including herself, weren't addressing the most powerful intervention for heart disease diet. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Dr. Marissa Russo trained to become a cancer biologist. She spent four years studying one of the deadliest brain tumors in adults and built her entire research career around a simple, urgent goal: open her own lab and improve the odds for patients with almost no shot at survival. In 2024 she applied for an F31 diversity grant through the NIH. The reviewers liked her work. Her resubmission was strong. Then the grant system started glitching. Dates vanished. Study sections disappeared. Emails went silent. When she finally reached a program officer, the message was clear: scrub the DEI language, withdraw, and resubmit. She rewrote the application in ten days. It failed. She had to start over. Again. This time with her identity erased.Marissa left the lab. She found new purpose as a science communicator, working at STAT News through the AAAS Mass Media Fellowship. Her story captures what happens when talent collides with institutional sabotage. Not every scientist gets to choose a Plan B. She made hers count.RELATED LINKSMarissa Russo at STAT NewsNIH F31 grant story in STATAAAS Mass Media FellowshipContact Marissa RussoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“People are not looking for a perfect, polished answer. They're looking for a human to speak to them like a human,” says Jessica Malaty Rivera, an infectious disease epidemiologist and one of the most trusted science communicators in the U.S. to emerge from the COVID-19 pandemic. That philosophy explains her relatable, judgement-free approach to communications which aims to make science more human, more accessible and less institutional. In this wide-ranging Raise the Line discussion, host Lindsey Smith taps Rivera's expertise on how to elevate science understanding, build public trust, and equip people to recognize disinformation. She is also keen to help people understand the nuances of misinformation -- which she is careful to define – and the emotional drivers behind it in order to contain the “infodemics” that complicate battling epidemics and other public health threats. It's a thoughtful call to educate the general public about the science of information as well as the science behind medicine. Tune in for Rivera's take on the promise and peril of AI-generated content, why clinicians should see communication as part of their professional responsibility, and how to prepare children to navigate an increasingly complex information ecosystem.Mentioned in this episode:de Beaumont Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast